Literature DB >> 26193825

The association between obesity and oligoclonal band formation in multiple sclerosis patients.

Arzu Çoban1, Denef Çevik2, Selen Özyurt2, Mehmet Gencer2, Erdem Tüzün3, Recai Türkoğlu2.   

Abstract

Since some neurological disorders present with increased body-mass index (BMI) and cerebrospinal fluid (CSF) oligoclonal bands (OCB), obesity-induced inflammation has been previously speculated in formation of OCB. We investigated the association between BMI, OCB formation and clinical features of MS in 120 patients with relapsing remitting multiple sclerosis (RRMS), a disease with high OCB positivity incidence. Thirty RRMS patients had BMI≥30 and 100 patients displayed CSF OCB. OCB positive and negative patients had comparable BMI and weight values. Disease duration, annual attack number and EDSS were not correlated with BMI and body weight. Patients with normal and high BMI did not significantly differ by means of OCB positivity, gender, annual attack number, disease duration and EDSS scores. Our results argue against a possible role of obesity in OCB formation. Moreover, obesity does not appear to influence disability and clinical progression of MS patients.
Copyright © 2015 Asian Oceanian Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body-mass index; Multiple sclerosis; Obesity; Oligoclonal band

Mesh:

Substances:

Year:  2015        PMID: 26193825     DOI: 10.1016/j.orcp.2015.07.001

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  2 in total

Review 1.  Insights into the Mechanisms That May Clarify Obesity as a Risk Factor for Multiple Sclerosis.

Authors:  Marije J D Huitema; Geert J Schenk
Journal:  Curr Neurol Neurosci Rep       Date:  2018-03-10       Impact factor: 5.081

2.  Association of Pre-Disease Body Mass Index With Multiple Sclerosis Prognosis.

Authors:  Ali Manouchehrinia; Anna Karin Hedström; Lars Alfredsson; Tomas Olsson; Jan Hillert; Ryan Ramanujam
Journal:  Front Neurol       Date:  2018-05-11       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.